The plaintiffs in this lawsuit allege that the defendants purportedly violated California law by allegedly concealing from the public that Gary Losse, M.D. was incompetent to render medical services, including performing surgery, because of his alleged long-term undisclosed addiction to narcotics.
Invokana, Invokamet, Jardiance, Xigduo XR, Farxiga, and Glyxambi are drugs used to treat Type 2 diabetes. An investigation is now looking into possible connections between these drugs and a serious condition called ketoacidosis.
This mass tort investigation alleges that the diabetes drug Onglyza can raise the risk of pancreatic cancer in patients and cause heart failure and death. Onglyza is made by AstraZeneca and has been approved by the FDA for the treatment of Type 2 diabetes.